High-Quality Tadalafil 171596-29-5 Manufacturer & Factory

1. Executive Summary & Chemical Profile: Tadalafil (CAS 171596-29-5)

Tadalafil (CAS Registry Number: 171596-29-5) represents a landmark compound in the class of phosphodiesterase type 5 (PDE5) inhibitors. Characterized by its unique pyrazinopyridoindole backbone, Tadalafil exhibits exceptional selectivity and prolonged terminal half-life (~17.5 hours) compared to short-acting analogues like Sildenafil and Vardenafil. As a premier active pharmaceutical ingredient (API) manufacturer and enterprise factory direct supplier, Gentolex delivers ultra-pure Tadalafil raw materials designed to meet stringent global pharmacopeia standards (USP, EP, JP, ChP).

2. Global Commercial Landscape & Industrial Market Dynamics

The global demand for Tadalafil (CAS 171596-29-5) continues to grow exponentially, driven by expanding therapeutic applications beyond conventional Erectile Dysfunction (ED) into Pulmonary Arterial Hypertension (PAH, marketed under formulations such as Adcirca) and Benign Prostatic Hyperplasia (BPH). Market insights indicate a compound annual growth rate (CAGR) of over 6.2% across mature and emerging pharmaceutical markets.

Industrial procurement managers and FDF (Finished Dosage Form) manufacturers encounter unique supply chain complexities, including fluctuating intermediate costs (e.g., D-Tryptophan methyl ester), tightening environmental standards on organic solvent utilization, and stringent regulatory oversight concerning nitrosamine and elemental impurities. As an enterprise-grade manufacturer possessing a construction area of 250,000 square meters, Gentolex mitigates these supply vulnerabilities through backward-integrated raw material synthesis, large-scale batch reproducibility, and multi-regional regulatory submission support.

3. Chemical Synthetic Route & Green Manufacturing Roadmap

The synthetic protocol for industrial-scale Tadalafil preparation relies on an optimized modified Pictet-Spengler reaction. Our R&D team has engineered a continuous flow chemistry paradigm that maximizes reaction yields while drastically minimizing halogenated solvent consumption and dangerous side reactions.

Synthetic Workflow Steps:

• Step 1: Condensation Chemistry — Reaction of D-tryptophan methyl ester hydrochloride with piperonal in the presence of trifluoroacetic acid (TFA) or mild organic acids to establish the cis-1,2-disubstituted tetrahydro-β-carboline core stereospecifically.
• Step 2: Chloroacetylation — Acylation of the secondary amine using chloroacetyl chloride under biphasic Schotten-Baumann conditions to yield the key crystalline intermediate.
• Step 3: Cyclization & Nucleophilic Substitution — Reaction with methylamine in aqueous/ethanolic medium to form the diketopiperazine ring system, completing the hexahydropyrazinopyridoindole skeleton of Tadalafil.
• Step 4: Particle Engineering & Crystallization — Controlled crystallization out of ethyl acetate/isopropanol systems yielding Form I crystals, followed by fluid-energy jet milling to produce customized Particle Size Distributions (PSD, e.g., D90 < 10 µm) for optimal oral bioavailability.

4. Macro Industry Solutions & Turnkey Services

Gentolex operates not merely as a raw material supplier, but as a full-spectrum solution provider for global pharmaceutical firms. Our operational framework spans across multiple key strategic service verticals: